Possibly....
SatiPharm, MMJ’s Swiss subsidiary has completed the development of Sativol, a proprietary gastro-resistant Cannabidiol (CBD) pill that being launched in Europe as dietary supplement, with first revenues from pill sales anticipated from August 2015.
Possibly.... SatiPharm, MMJ’s Swiss subsidiary has completed the...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HGV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.622M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 239343 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 27386 | 1 |
View Market Depth
| Last trade - 10.04am 05/09/2024 (20 minute delay) ? |
| HGV (ASX) Chart |
Day chart unavailable